The company: Par Health Issues Voluntary Nationwide Recall of Argatroban Injection Due to the Presen
A record notice: the source is linked, and no summary was written because none passed the fact check.
A record about The company was published on October 14, 2026. readthrough could not produce a summary that passed its fact check, so this notice carries only the record's own title. Read it: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/par-health-issues-voluntary-nationwide-recall-argatroban-injection-due-presence-particulate-matter
Fact check notes
- NoticeNo cited sentence survived the fact check, so no summary was published.
- NoticeThis notice was built from the record's own index, not written by the model.
This is a record notice. readthrough could not write a summary that passed its fact check, so the headline and text above come from the record’s own index. The source is linked. Not investment advice.